Drug studies in animals
Last updated: 2024 Apr 18
Total hit(s): 812
S.No.
1
38594459
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection.
Sci Rep
2024 Apr 9
4.12
1
2
38438233
Mass spectrometry study on SARS-CoV-2 recombinant vaccine with comprehensive separation techniques to characterize complex heterogeneity.
Anal Chim Acta
2024 Apr 8
5.31
1
3
38588829
Throat spray formulated with virucidal Pharmaceutical excipients as an effective early prophylactic or treatment strategy against pharyngitis post-exposure to SARS CoV-2.
Eur J Pharm Biopharm
2024 Apr 6
1
4
38575586
The metabolic footprint of Vero E6 cells highlights the key metabolic routes associated with SARS-CoV-2 infection and response to drug combinations.
Sci Rep
2024 Apr 4
4.12
1
5
38608595
In vitro pharmacokinetic behavior in lung of harringtonine, an antagonist of SARS-CoV-2 associated proteins: New insights of inhalation therapy for COVID-19.
Phytomedicine
2024 Apr 4
7.2
1
6
38597182
Enteric coronavirus nsp2 is a virulence determinant that recruits NBR1 for autophagic targeting of TBK1 to diminish the innate immune response.
Autophagy
2024 Apr 16
10.79
1
7
38607375
Genotoxicity and safety pharmacology of the rVSVInd(GML)-mspSGtc vaccine against SARS-CoV-2 in Sprague-Dawley rats and Beagle dogs.
Arch Toxicol
2024 Apr 12
5.66
1
8
38607273
The mouse to man conundrum: Revisiting an old lung injury model to study repurposed drugs for COVID-19 treatment.
Exp Physiol
2024 Apr 12
4.3
1
N/A
9
38573021
Ursodeoxycholic acid may protect from severe acute respiratory syndrome coronavirus 2 Omicron variant by reducing angiotensin-converting enzyme 2.
Pharmacol Res Perspect
2024 Apr
3.3
1
10
38479071
Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity.
Virology
2024 Mar 7
2.819
1
11
38547259
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model.
Science
2024 Mar 29
20.57
1
12
38554446
Strategic development of a self-adjuvanting SARS-CoV-2 RBD vaccine: From adjuvant screening to enhanced immunogenicity with a modified TLR7 agonist.
Int Immunopharmacol
2024 Mar 29
3.38
1
13
37544514
Niclosamide: A career builder PART I: (Almost) Everything You Wanted To Know About Niclosamide But Were Too Afraid To Ask PART II: Nanomedicines? A Carrier-Free Nanomedicine for Cancer and a Simple Buffered Solution to Prevent COVID19 and Other Respiratory Infections: They Just Need Testing Invited Manuscript: J Controlled Release VSI in Honor of Prof. Park.
J Control Release
2024 Mar 21
15.5
1
14
38543849
A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against beta-Coronaviruses in a Murine Model.
Viruses
2024 Mar 21
3.76
1
15
38486021
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination.
Nat Immunol
2024 Mar 14
18.5
1
16
38472181
Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2.
Nat Commun
2024 Mar 12
11.8
1
17
38466126
In Silico and In Vitro Screening of Some Pregnane Glycosides Isolated from Certain Caralluma Species as SARS-COV-2 Main Protease Inhibitors.
Chem Biodivers
2024 Mar 11
1
18
38471595
Distribution and suitability of pulmonary surfactants as a vehicle for topically applied antibodies in healthy and SARS-CoV-2 infected rodent lungs.
Eur J Pharm Sci
2024 Mar 10
3.66
1
19
38445768
A superior heterologous prime-boost vaccination strategy against COVID-19: A bivalent vaccine based on yeast-derived RBD proteins followed by a heterologous vaccine.
J Med Virol
2024 Mar
2.07
1
20
38527094
Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo.
PLoS Pathog
2024 Mar
6.18
1
21
38425270
A subunit-based influenza/SARS-CoV-2 Omicron combined vaccine induced potent protective immunity in BALB/c mice.
J Med Virol
2024 Mar
2.07
1
22
38340419
Fourth dose of microneedle array patch of SARS-CoV-2 S1 protein subunit vaccine elicits robust long-lasting humoral responses in mice.
Int Immunopharmacol
2024 Feb 9
3.38
1
23
38341953
A validated LC-MS/MS method for determination of six Anti-SARS-CoV-2 drugs in plasma and its application for a pharmacokinetic study in rats.
J Chromatogr B Analyt Technol Biomed Life Sci
2024 Feb 7
1
24
38320990
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination.
Cell Discov
2024 Feb 6
4.65
1
25
38340650
A tale of lockdown policies on the transmission of COVID-19 within and between Chinese cities: A study based on heterogeneous treatment effect.
Econ Hum Biol
2024 Feb 5
3.4
1